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54 The Journal of Thoracic and Cardiobjectives: (1) To examine the interaction of donor age with ischemic time and their
ffect on survival and (2) to define ranges of ischemic time associated with
ifferences in survival.
ethods: The United Network for Organ Sharing provided de-identified patient-
evel data. The study population included 33,640 recipients undergoing heart trans-
lantation between October 1, 1987, and December 31, 2004. Recipients were
ivided by donor age into terciles: 0 to 19 years (n 10,814; 32.1%), 20 to 33 years
11,410, 33.9%), and 34 years or more (11,416, 33.9%). Kaplan-Meier survival
unctions and Cox regression were used for time-to-event analysis. Receiver oper-
ting characteristic curves and stratum-specific likelihood ratios were generated to
ompare 5-year survival at various thresholds for ischemic time.
esults: In univariate Cox proportional hazards regression, the effect of ischemic
ime on survival varied by donor age tercile: 0 to 19 years (P .141), 20 to 33 years
P  .001), and 34 years or more (P  .001). These relationships persisted in
ultivariable regression. Threshold analysis generated a single stratum (0.37-12.00
ours) in the 0- to 19-year-old group with a median survival of 11.4 years. However,
n the 20- to 33-year-old-group, 3 strata were generated: 0.00 to 3.49 hours (limited),
.50 to 6.24 hours (prolonged), and 6.25 hours or more (extended), with median
urvivals of 10.6, 9.9, and 7.3 years, respectively. Likewise, 3 strata were generated
n the group aged 34 years or more: 0.00 to 3.49 (limited), 3.50 to 5.49 (prolonged),
nd 5.50 or more (extended), with median survivals of 9.1, 8.5, and 6.3 years,
espectively.
onclusions: The effect of ischemic time on survival after heart transplantation is
ependent on donor age, with greater tolerance for prolonged ischemic times among
rafts from younger donors. Both donor age and anticipated ischemic time must be
onsidered when assessing a potential donor.
uring the past 30 years of heart transplantation, it has become common
practice to procure hearts from younger donors even when extended isch-
emic times are required. However, among older donors, convention dictates
hat ischemic time should be limited to 4 hours or less.
To test these practices, this study examined the effect of ischemic time on
ecipient survival within various donor age ranges. In addition, it sought to define
hresholds for ischemic time associated with worse survival within these donor age
roups. To achieve sufficient power to detect differences in survival across a broad
ange of ischemic times, we analyzed the United Network for Organ Sharing
UNOS) registry, which includes all heart transplants from US centers since 1987.
vascular Surgery ● February 2007
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TXaterials and Methods
ata Collection and Study Population
NOS provided de-identified patient-level data from the Thoracic
egistry (data source No. 092005-7). The registry includes all
eart transplant recipients and donors in the United States since
ctober 1, 1987. This study included 34,556 heart transplants
erformed from October 1, 1987, to December 31, 2004. Patients
ith a previous heart transplant were excluded from the study
opulation (n 916, 2.5%). Recipients were divided by donor age
nto terciles: 0 to 19 years (n  10,814; 32.2%), 20 to 33 years
11,410, 33.9%), and 34 years or more (11,416, 33.9%).
ata Analysis
ll data were analyzed with a standard statistical software pack-
ge, Stata 9 (Stata Corp, College Station, Tex). Continuous vari-
bles were reported as means  standard deviation and compared
sing the Student’s t test. The chi-square test was used to compare
ategoric variables. All reported P values were 2-sided.
The primary outcome measure was survival reported as median
urvival and incidence rate of death per 100 patient-years with
5% confidence intervals (CIs). Kaplan–Meier analysis with Cox
roportional hazards regression was used for time-to-event analy-
is. Outcome of interest was death (n 13,478, 40.1%) or retrans-
lant (n  840, 2.5%), whichever came first. Patients lost to
ollow-up (n  2,168, 6.44%) or alive on September 15, 2005
17,154, 51.0%) were censored at the date of last known follow-
p. A multivariate Cox regression was performed (backward,
emove P .10) in which the dependent variable was survival and
he independent variables were donor age, recipient age, ischemic
ause of disease, intensive care unit immediately before transplant,
NOS status 1/1A/1B at transplant, waiting time, year of trans-
lant, and ischemic time. To assess the impact of ischemic time on
arly and late mortality, the incidence rate of death per 100
atient-years was calculated at multiple time intervals (30 days,
0 days to 1 year, 1-5 years, 5-10 years, and 10 years). Receiver
perating characteristic (ROC) curves and stratum-specific likeli-
ood ratios (SSLRs) were used in threshold analysis. ROC curves
ere generated by plotting sensitivity on the ordinate and 1-spec-
ficity on the abscissa with ischemic time as a continuous variable
nd mortality (at 5 years) as a binary outcome.1,2 SSLRs and 95%
Is were generated using data cut-points at regular intervals as
reviously described.3,4 Cut-points, or threshold values, for isch-
mic time were determined by combining adjacent ischemic time
trata in 15-minute (0.25 hours) intervals with other statistically
ndistinct strata based on the presence of SSLRs with overlapping
5% CIs. Cut-points occurred when 2 statistically distinct strata
ould be formed. This process was repeated until no additional
Abbreviations and Acronyms
CI  confidence interval
ROC  receiver operating characteristic
SSLR  stratum-specific likelihood ratio
UNOS  United Network for Organ Sharingut-points were found. a
The Journal of Thoracicesults
tudy Population
nalysis included 178,031.1 at-risk years with a median
urvival of 10.3 years. The mean ischemic time for the 0- to
9-year-old, 20- to 33-year-old, and 34-year-old donor
erciles was 3.1 1.2 hours, 2.8 1.0 hours, and 2.9 1.0
ours, respectively. Table 1 summarizes recipient and donor
haracteristics by donor age terciles and ischemic time
trata.
urvival Analysis
n univariate Cox proportional hazards regression, the effect
f ischemic time on survival varied by donor age terciles: 0
o 19 years (P  .141), 20 to 33 years (P  .001), and 34
ears or more (P  .001). In multivariate analysis, increas-
ng donor age (P  .006), increasing recipient age (P 
001), and earlier year of transplant (P  .001) were asso-
iated with worse survival in the 19-year-old donor age
ercile; increasing donor age (P  .001), increasing recipi-
nt age (P  .001), ischemic cause (P  .001), intensive
are unit pretransplant (P  .004), earlier year of transplant
P  .001), and increasing ischemic time (P  .001) were
ssociated with worse survival in the 20- to 33-year-old
onor age tercile; and increasing donor age (P  .001),
ncreasing recipient age (P  .014), ischemic cause (P 
001), intensive care unit pretransplant (P  .004), earlier
ear of transplant (P  .001), and increasing ischemic time
P  .001) were associated with worse survival in the
34-year-old donor age tercile. Table 2 demonstrates a
rend toward an increase in the incidence rate of death at
early every time point.
eceiver Operating Characteristic
OC curves and the corresponding area under the curve
ere 0.53 (0.52-0.55), 0.52 (0.51-0.53), and 0.53 (0.52-
.55) for the 0- to 19-year-old, 20- to 33-year-old, and
34-year-old donor groups, respectively. The results of
hreshold analysis are presented in Table 2. SSLR anal-
sis generated only a single stratum (0.37-12.00 hours) in
he 0- to 19-year-old group with a median survival of
1.4 years; however, in the 20- to 33-year-old group, 3
trata were generated: 0.00 to 3.49 hours (limited) with
n SSLR of 0.97 (0.94-0.99) and median survival of 10.6
ears; 3.50 to 6.24 hours (prolonged) with an SSLR of
.11 (1.01-1.23) and median survival of 9.9 years; and
.25 hours or more (extended) with an SSLR of 2.87
1.29-6.40) and median survival of 7.3 years. Likewise, 3
trata for ischemic time were generated in the 34-year-
ld group: 0.00 to 3.49 hours (limited) with an SSLR of
.94 (0.92-0.97) and median survival of 9.1 years; 3.50 to
.49 hours (prolonged) with an SSLR of 1.15 (1.06-1.27)
nd median survival of 8.5 years; and 5.50 hours or more
and Cardiovascular Surgery ● Volume 133, Number 2 555
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TXextended) with an SSLR of 2.4 (1.48-3.97) and median
urvival of 6.3 years.
iscussion
revious studies exploring the relationship between isch-
mic time and survival have reported conflicting findings. A
umber of studies examining determinants of long-term
urvival demonstrated an inverse relationship between isch-
mic time and posttransplant survival,5,6 whereas other
tudies found no association between ischemic time and
urvival.7-9 These conflicting findings may result from lim-
tations in sample size or range of ischemic times. It is also
ossible that other donor characteristics influencing toler-
nce for cold ischemia were not considered. By examining
ABLE 1. Recipient–donor characteristics by donor age te
onor age tercile Years old <19
schemic time h
n 10,814
ean donor age y 12.9 6.3
ean recipient age y 36.3 23.4
schemic cause of heart failure n% 3553
32.9%
aiting time d SD 120.1 200.5
NOS status 1 at transplant n% 6477
59.9%
CU at time of transplant n% 5616
51.9%
NOS, United Network for Organ Sharing; ICU, intensive care unit; SD, st
ABLE 2. Outcomes by donor age terciles and ischemic ti
onor age tercile Years old <19
schemic time h
tratum-specific likelihood ratio
95% CI
edian survival y 11.4
ncidence rate of death
Overall /100 person*y 6.5
95% CI (6.3-6.7)
0-30 d /100 person*y 76.9
95% CI (71.2-83
30 d to 1 y /100 person*y 9.5
95% CI (8.9-10.2
1-5 y /100 person*y 4.0
95% CI (3.8-4.2)
5-10 y /100 person*y 5.3
95% CI (5.0-5.7)
10 y /100 person*y 7.9
95% CI (7.2-8.7)I, Confidence interval.
56 The Journal of Thoracic and Cardiovascular Surgery ● Febrhe national experience with heart transplantation over the
ast 2 decades and considering the effect of donor age on
olerance for cold ischemia, this study overcomes the limi-
ations of previous studies.
The findings in this study demonstrate that the impact
f ischemic time on survival differs by donor age. Among
onors aged 19 years or less, there was no statistically
ignificant relationship between ischemic time and sur-
ival. Furthermore, in threshold analysis, no threshold
ould be found in which a significant difference in sur-
ival existed. It is possible that the heterogeneity of
ecipients in the 19-year-old donor age tercile con-
ounded the relationship between ischemic time and sur-
ival in this tercile, but further analysis not presented
s and ischemic time strata
20-33
Limited Prolonged Extended Subtotal
0.00-3.49 3.50-6.24 6.25
10,817 547 46 11,410
5.6 4.1 25.7 4.1 25.5 4.1 25.6  4.1
9.7 12.5 48.7 14.9 48.1 15.6 49.8  12.6
5247 277 22 5546
48.5% 50.6% 47.8% 48.6%
1.5 237.4 164 252.3 270.1 372.7 152.6  239.0
6281 393 30 6704
58.1% 71.8% 65.2% 58.8%
4943 259 9 5211
45.7% 47.3% 19.6% 45.7%
d deviation; CI, confidence interval.
trata
20-33
Limited Prolonged Extended Subtotal
0.00-3.49 3.50-6.24 6.25
0.97 1.11 2.87
(0.94-0.99) (1.01-1.23) (1.29-6.40)
10.6 9.9 7.3 10.5
6.9 7.9 14.5 7.1
(6.7-7.1) (7.4-8.4) (9.5-22.3) (6.9-7.3)
54.7 83.5 225.6 61.8
(49.5-60.5) (71.8-97.0) (107.5-473.2) (56.9-67.2)
9.4 8.9 6.8 9.3
(8.7-10.2) (7.7-10.3) (1.7-27.3) (8.7-10.0)
4.4 4.7 10.9 4.5
(4.1-4.6) (4.2-5.3) (5.4-21.8) (4.2-4.7)
6.5 7.3 9.1 6.6
(6.1-6.9) (6.4-8.3) (2.9-28.3) (6.3-7.0)
9.5 11.6 16.8 9.8
(8.7-10.4) (9.5-14.2) (2.4-118.9) (9.0-10.6)rcile
2
4
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TXere suggests that this was unlikely. Multivariable Cox
roportional hazards regression analysis, as described
bove, limited to narrower recipient age ranges (1 year,
-6 years, 6-11 years, 12-18 years, and 18 years) was
lso unable to demonstrate a statistical relationship be-
ween ischemic time and survival in any recipient age
ange.
Conversely, among the 2 older donor age terciles
20-33 years and 34 years), a statistically significant
elationship was observed between ischemic time and
urvival. In threshold analysis, survival was diminished
n both the 20- to 33-year-old and 34-year-old terciles
ith prolonged ischemic times (3.50-6.24 hours and
.50-5.49 hours, respectively), and posttransplant sur-
ABLE 1. Continued
>34
Limited Prolonged Ex
0.00-3.49 3.50-5.49 
9224 2051
43.7 7.0 44.6 4.1 43.5
52  11.4 51.5 13.3 52.7
4625 1085
50.1% 52.9% 5
162.7 241.9 187.5 274.8 166.5
5573 1453
60.4% 70.8% 6
4230 1053
45.9% 51.3% 4
ABLE 2. Continued
>34
Limited Prolonged Ex
0.00-3.49 3.50-5.49 
0.94 1.15
(1.06-1.27) (1.48-3.97)
9.1 8.5
8.4 9.7
(8.1-8.7) (9.1-10.2) (1
84.1 119.7 2
(77.3-91.4) (106.0-135.2) (15
11.2 12.7
(10.4-12.1) (11.3-14.3) (1
5.3 5.6
(5.0-5.7) (5.0-6.2) (4
7.5 7.2
(7.0-8.0) (6.3-8.3) (1
10.4 11.2
(9.3-11.7) (8.8-14.4) (6I, Confidence interval.
The Journal of Thoracicival was further diminished with extended ischemic
imes (6.25 hours and 5.50 hours, respectively). It
hould be noted that when comparing limited with pro-
onged ischemic times in both of these older donor age
erciles, survival was diminished by less than 250 days.
herefore, although a statistically significant difference
n survival existed, the difference was of little clinical
onsequence. However, when comparing limited with
xtended ischemic times within both of these older age
roups, the median survival decreased by more than 1000
ays. Furthermore, when moving within each of the 2
lder donor age terciles from the limited to prolonged to
xtended strata, there is a trend at nearly every time point
oward an increase in the incidence rate of death
Totald Subtotal
11,416 33,640
.4 43.7 7.0 43.7 7.0
3.5 52 11.6 46.2 18.0
5788 14,887
50.7% 44.3%
43.8 163.6 243.2 145.8 229.7
7124 20,305
62.4% 60.4%
5350 16,177
46.9% 48.1%
Totald Subtotal
8.9 10.3
8.7 7.4
.2) (8.5-9.0) (7.3-7.5)
94.6 77.7
7.8) (88.4-101.3) (74.4-81.2)
11.7 10.2
.1) (11.0-12.4) (9.8-10.5)
5.4 4.6
.2) (5.1-5.7) (4.5-4.8)
7.4 6.4
.1) (7.0-7.9) (6.2-6.6)
10.6 9.3
.1) (9.6-11.8) (8.8-9.8)tende
5.50
141
 7
 1
78
5.3%
 2
98
9.5%
67
7.5%tende
5.50
2.42
6.3
15.0
1.7-19
37.8
8.0-35
21.5
3.6-34
6.8
.1-11
3.6
.2-11
18.0
.8-48and Cardiovascular Surgery ● Volume 133, Number 2 557
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TXTable 2). Therefore, it seems that in these donor age
anges, the negative impact of longer ischemic times on
urvival persists over time.
imitations
ecipient–donor characteristics were not uniform across
roups. However, potential differences in pretransplant re-
ipient morbidity or donor quality were unlikely to con-
ound comparisons of ischemic time strata within the same
onor age terciles and, therefore, the findings in this study.
s summarized in Table 1, there is little evidence that,
ithin the same donor age terciles, recipients of grafts
ubjected to longer ischemic times were sicker. In fact,
hen the prolonged and extended strata within each of the
older donor age terciles were compared, the extended
trata had a lower percentage of patients admitted to the
ntensive care unit pretransplant and relatively fewer pa-
ients with UNOS status 1/1A/1B. Moreover, even when
sing multivariable Cox proportional hazards regression to
ontrol for other patients’ characteristics, the observed re-
ationship between ischemic time and survival persisted.
onversely, because donor and recipient characteristics
nown to influence posttransplant survival, including recip-
ent age, varied widely across donor age terciles and regres-
ion analysis was not performed to control for differences,
omparisons between ischemic time strata from different
onor age terciles should be made with caution.
Finally, although there was no measurable effect of isch-
mic time on hearts from donors aged 19 years or less
ithin the given ranges of ischemic time, there is undoubt-
dly some duration of ischemic time in which survival is
dversely affected. However, given the distribution of isch-
mic times observed in this study, this threshold could not
e determined.
onclusions
he findings in this study demonstrate that the effect of
schemic time on survival is dependent on donor age. These
ndings support the practice of procuring hearts from
ounger donors even when extended ischemic times are
equired. With adult-aged donors, a more conservative ap-
roach to ischemic time is justified, but in fact, when older
rgans are subjected to ischemic times up to 5.5 hours, they
ffer long-term survival comparable to those with shorter
schemic times. Nevertheless, clinically important differ-
nces in survival are observed when ischemic times extend
eyond 5.5 to 6.25 hours, especially among recipients of
earts from advanced-age donors. Implicit in this observa-
ion is that stacking of risk factors (eg, subjecting grafts
rom advanced-age donors to extended ischemic times) pre-
icts poor outcomes.
We thank UNOS for supplying these data and Katarina Ander-
on for her assistance with our analysis.
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imited, prolonged, and extended ischemic times. C, Donors ageduary 2007
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